dc.contributor.author | Thorat, MA | en_US |
dc.date.accessioned | 2016-07-26T12:04:07Z | |
dc.date.available | 2016-06-23 | en_US |
dc.date.issued | 2016-07-06 | en_US |
dc.date.submitted | 2016-07-08T13:09:28.212Z | |
dc.identifier.issn | 1741-7015 | en_US |
dc.identifier.other | 10.1186/s12916-016-0648-9 | |
dc.identifier.other | ARTN 101 | en_US |
dc.identifier.other | ARTN 101 | en_US |
dc.identifier.other | ARTN 101 | en_US |
dc.identifier.other | ARTN 101 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/13684 | |
dc.description | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BMC MEDICINE | en_US |
dc.subject | Aspirin | en_US |
dc.subject | Prevention | en_US |
dc.subject | Cancer | en_US |
dc.subject | Cardiovascular disease | en_US |
dc.subject | Benefit-harm balance | en_US |
dc.subject | Bleeding | en_US |
dc.subject | Gastrointestinal | en_US |
dc.subject | Modelling | en_US |
dc.subject | Personalised medicine | en_US |
dc.title | Individualised benefit-harm balance of aspirin as primary prevention measure - a good proof-of-concept, but could have been better ... | en_US |
dc.type | Article | |
dc.rights.holder | The Author(s). 2016 | |
dc.identifier.doi | 10.1186/s12916-016-0648-9 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000379737500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 14 | en_US |
qmul.funder | Cancer Prevention::Cancer Research UK | en_US |